Cerebral Microbleeds Associate with Brain Endothelial Cell Activation-Dysfunction and Blood-Brain Barrier...

Area of Science:

• Neurology
• Radiology
• Geriatrics

Background:

• Cerebral microbleeds (CMBs) are increasingly recognized as indicators of cerebral small vessel disease (SVD).
• Brain endothelial cell and blood-brain barrier dysfunction are associated with SVD, enlarged perivascular spaces, and CMB development.
• CMBs are common in older adults, posing a growing healthcare challenge due to global population aging.

Purpose of the Study:

• To highlight the significance of cerebral microbleeds (CMBs) in the context of aging and neurological disorders.
• To emphasize the association between CMBs and increased risk of stroke and dementia.
• To underscore the need for further research into CMB development, evolution, and their impact on cognition and neurodegeneration.

Main Methods:

• Review of existing literature on cerebral microbleeds (CMBs).
• Analysis of CMBs as markers for cerebral small vessel disease (SVD).
• Correlation of CMBs with stroke, dementia, and neurodegenerative processes.

Main Results:

• CMBs are hypointense lesions on specific MRI sequences (T2*-weighted, susceptibility-weighted).
• Increased CMBs (≥10) indicate a higher risk of symptomatic intracerebral hemorrhages.
• CMBs serve as markers for diffuse vascular and neurodegenerative brain damage.

Conclusions:

• Cerebral microbleeds (CMBs) are critical indicators of SVD and associated neurological risks.
• Understanding CMBs is essential for addressing the growing healthcare burden of stroke, dementia, and neurodegeneration in aging populations.
• Further investigation into CMBs' role in cognitive impairment and neurodegeneration is warranted.